Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Qualitative Perfusion Cardiac Magnetic Resonance Imaging Lacks Sensitivity in Detecting Cardiac Allograft Vasculopathy.

Cardiology research·2017
Same author

Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee.

Journal of cardiac failure·2015
Same author

Echocardiographic Ramp test for continuous-flow left ventricular assist devices: do loading conditions matter?

JACC. Heart failure·2015
Same author

Impact of pre-transplant pulmonary hypertension on survival after heart transplantation: a UNOS registry analysis.

International journal of cardiology·2014
Same author

Substance abuse at the time of left ventricular assist device implantation is associated with increased mortality.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2014
Same author

Driveline infection after HeartMate II associated with lower rates of cardiac transplantation and increased incidence of sepsis in bridge-to-transplant population.

Minnesota medicine·2014

Related Experiment Video

Updated: Jun 3, 2026

Murine Cervical Aortic Transplantation Model using a Modified Non-Suture Cuff Technique
10:11

Murine Cervical Aortic Transplantation Model using a Modified Non-Suture Cuff Technique

Published on: November 2, 2019

Cardiac allograft vasculopathy: current knowledge and future direction.

Monica Colvin-Adams1, Adheesh Agnihotri

  • 1University of Minnesota, Minneapolis, MN, USA. colvi005@umn.edu

Clinical Transplantation
|April 5, 2011
PubMed
Summary

Cardiac allograft vasculopathy (CAV) is a major cause of death after heart transplantation. Understanding its risk factors, pathogenesis, and early diagnosis using methods like intravascular ultrasound (IVUS) is crucial for improving patient outcomes.

More Related Videos

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique
10:32

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique

Published on: October 12, 2014

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft
08:30

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft

Published on: February 14, 2022

Related Experiment Videos

Last Updated: Jun 3, 2026

Murine Cervical Aortic Transplantation Model using a Modified Non-Suture Cuff Technique
10:11

Murine Cervical Aortic Transplantation Model using a Modified Non-Suture Cuff Technique

Published on: November 2, 2019

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique
10:32

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique

Published on: October 12, 2014

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft
08:30

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft

Published on: February 14, 2022

Area of Science:

  • Cardiology
  • Transplantation Immunology
  • Vascular Biology

Background:

  • Cardiac allograft vasculopathy (CAV) is a significant cause of late mortality in heart transplant recipients.
  • Despite improvements in transplant survival, CAV remains a critical clinical challenge.
  • It represents a unique form of accelerated coronary artery disease in the transplanted heart.

Purpose of the Study:

  • To review the multifaceted risk factors contributing to CAV development.
  • To elucidate the complex pathogenesis involving immunological and non-immunological pathways.
  • To discuss current and emerging diagnostic strategies for early CAV detection.

Main Methods:

  • Review of existing literature on CAV risk factors, pathogenesis, and diagnosis.
  • Analysis of traditional (dyslipidemia, diabetes, hypertension) and non-traditional (CMV infection, HLA mismatch, rejection) risk factors.
  • Evaluation of diagnostic modalities including intravascular ultrasound (IVUS), angiography, echocardiography, CT, and MRI.

Main Results:

  • CAV results from a complex interplay of factors leading to endothelial injury and intimal proliferation.
  • Risk factors encompass traditional cardiovascular elements and transplant-specific immunological challenges.
  • Intravascular ultrasound (IVUS) is highlighted as a valuable prognostic tool, though angiography remains a benchmark.

Conclusions:

  • Early diagnosis of CAV is essential due to asymptomatic presentation in denervated hearts.
  • A comprehensive understanding of risk factors and pathogenesis is key to managing CAV.
  • Advancements in diagnostic techniques, particularly IVUS, aid in patient management and prognosis assessment.